{
  "12551724-DS-13": " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nCodeine\n \nAttending: ___.\n \nChief Complaint:\nRLE swelling\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year-old gentleman with history significant for \nhyperlipidemia, diabetes mellitus type 2, hypertension, left \nventricular dysfunction with an EF of 40%-45%, coronary artery \ndisease, status post bypass with LIMA to LAD, SVG to the PLV and \nPDA, and SVG to OM1 and OM2, left leg DVT, CKD stage II ___ \ndiabetic nephropathy, presents with right leg swelling.  \n Right leg swelling started ___ morning, he woke up this \nway. No pain at this time. ___, swelling worsened, but he \nstill went to work for 6 hours standing on it, felt febrile so \nchecked his temperature and was 99/8. ___, swelling and \npain worsened before it got better, he tried very hard to stay \noff of it. He remembered having similar pain in ___ when he had \na left leg clot. Since his pain did not improve, he came into \nthe ED where he was found to have a DVT. On the walk up to the \nED, he felt some shortness of breath, otherwise no symptoms of \nchest pain or shortness of breath at the moment.  \n Of note, patient states he got an extensive work up done at ___ \nwhich showed he had factor 5.  \n ED COURSE  \n - Exam: Notable for \"unilateral 2+ pitting edema in the right \ncalf, positive Homans sign\"  \n - Labs:  \n BMP  \n 142 | 104 | 16 / AGap=18  \n ------------------ 177  \n 5.1 | 20 | 1.1 \\  \n CBC  \n \\ 12.2 /  \n 6.8 ------ 112  \n / 36.0 \\ 71.3%N, 17.5%L  \n INR 1.1; PTT 29  \n - Imaging:  \n BLE U/S ___:  \n 1. Occlusive thrombosis of the right femoral vein, right \npopliteal vein, right posterior tibial veins, and right peroneal \nveins.  \n 2. No evidence of deep venous thrombosis in the left lower \nextremity.  \n CTA Chest ___:  \n 1. Pulmonary emboli of the lobar, segmental, and subsegmental \npulmonary arteries to the right middle and right lower lobes.  \n 2. Multiple pulmonary nodules, as detailed above, measuring up \nto 6 mm in the right upper and left upper lobes. Comparison with \nprior chest CT, if available, is recommended. If not available, \nchest CT in 12 months is optional if patient has elevated risk \nfactors for lung cancer. If there are no elevated risk factors, \nfollow-up chest CT is not recommended. This is per ___ \n___ guidelines on incidentally found pulmonary nodules.  \n - Cardiology:  \n EKG ___: Rate 76, RAD, LBBB, no signs of ischemia  \n - Consults: None  \n - Interventions: ASA 325, Lisinopril 40, Carvedilol 12.5, \nIsosorbide (ER) 120, Metoprolol 25. Heparin gtt.  \n\n \nPast Medical History:\nCAD/MI (___)\nHTN\nHyerlipidemia\nDM\n\n \nSocial History:\n___\nFamily History:\nMother: lung cancer, heavy smoker\nCousin: Factor 5 ___\nUncle: MI\n \nPhysical ___:\nADMISSION PE:\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\nPHYSICAL EXAM:\nVs: 98.1 PO 184 / 104 R Sitting 80 18 98 Ra  \n Gen: Well-appearing male in NAD.  \n Eyes: No scleral icterus. EOMI. PERRL.  \n HENT: NC/AT. Neck supple, no tenderness. No LAD.  \n CV: NR, RR. Nl S1, S2. No m/r/g. 2+ peripheral pulses \nbilaterally.  \n Resp: CTAB. Resonant to percussion throughout.  \n GI: Soft, nontender, nondistended. No masses.  \n Msk: RLE with 2+ pitting edema. LLE w no edema.  \n Skin: No rashes or lesions.  \n Neuro: AOx3. Moving all four limbs with intention.  \n\nDISMISSION PE:\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\nPHYSICAL EXAM:  \n Vitals: T 98.0, BP 160/83, HR 71, RR 18, O2 Sat 97 Ra  \n Gen: NAD, laying comfortably in bed.  \n Eyes: No scleral icterus. PERRL.  \n CV: RRR. Nl S1, S2. No m/r/g. No ___ carotid bruits.\n Resp: decreased breath sounds R upper/lower, CTA on L, no \nwheezes/ rhonchi/ rales. No evidence of accessory muscle use on \nrespiration.  \n GI: Soft, nontender, nondistended. No masses.  \n Msk: Trace edema RLE up to ankle, no erythema/ tenderness, or \nassociated skin findings concerning for limb ischemia, wwp, 2+ \ndistal pulses ___, LLE with no edema; - ___ sign RLE. \n Skin: No rashes or lesions.  \n Neuro: AOx3. Grossly moving all four limbs with purpose. \n\n \nPertinent Results:\nADMISSION LABS:\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\n___ 10:53AM BLOOD WBC-6.8 RBC-3.52* Hgb-12.2* Hct-36.0* \nMCV-102* MCH-34.7* MCHC-33.9 RDW-12.6 RDWSD-46.6* Plt ___\n___ 10:53AM BLOOD Neuts-71.3* Lymphs-17.5* Monos-8.5 \nEos-1.8 Baso-0.6 Im ___ AbsNeut-4.86 AbsLymp-1.19* \nAbsMono-0.58 AbsEos-0.12 AbsBaso-0.04\n___ 06:00AM BLOOD Glucose-147* UreaN-13 Creat-1.0 Na-143 \nK-4.4 Cl-102 HCO3-25 AnGap-16\n___ 10:53AM BLOOD ___ PTT-29.0 ___\n___ 06:00AM BLOOD Calcium-8.8 Phos-3.6 Mg-1.5*\n\nIMAGING:\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\n___ ECG:\nRate PR QRS QT QTc (___)    P QRS T \n76 ___               -14 122 58 \n\n___ ___ US:\nIMPRESSION:   \n1. Occlusive thrombosis of the right femoral vein, right \npopliteal vein, right \nposterior tibial veins, and right peroneal veins. \n2. No evidence of deep venous thrombosis in the left lower \nextremity. \n\n___ CTA CHEST:\nIMPRESSION:   \n1. Pulmonary emboli of the lobar, segmental, and subsegmental \npulmonary \narteries to the right middle and right lower lobes. \n2. Multiple subcentimeter pulmonary nodules, as detailed above, \nmeasuring up \nto 6 mm in the right upper and left upper lobes.  Comparison \nwith prior chest \nCT, if available, is recommended.  If not available, chest CT in \n12 months is \noptional if patient has elevated risk factors for lung cancer.  \nIf there are \nno elevated risk factors, follow-up chest CT is not recommended. \n This is per \n___ society guidelines on incidentally found pulmonary \nnodules. \n\nDISCHARGE LABS:\n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\n___ 06:00AM BLOOD WBC-5.4 RBC-3.06* Hgb-11.0* Hct-31.8* \nMCV-104* MCH-35.9* MCHC-34.6 RDW-12.7 RDWSD-47.8* Plt ___\n___ 06:00AM BLOOD ___ PTT-73.0* ___\n___ 06:00AM BLOOD Glucose-147* UreaN-13 Creat-1.0 Na-143 \nK-4.4 Cl-102 HCO3-25 AnGap-16\n___ 06:00AM BLOOD Calcium-8.8 Phos-3.6 Mg-1.5*\n \nBrief Hospital Course:\n___ year-old gentleman with history significant for \nhyperlipidemia, diabetes mellitus type 2, hypertension, left \nventricular dysfunction with an EF of 40%-45% (___), \ncoronary artery disease, status post bypass with LIMA to LAD, \nSVG to the PLV and PDA, and SVG to OM1 and OM2, left leg DVT \n___, CKD stage II ___ diabetic nephropathy, presenting with \nright leg swelling. \n\n============  \n ACUTE ISSUES  \n ============  \n # RLE DVT\n #Pulmonary Embolism \nPatient presented with RLE DVT after noticing RLE swelling on \n___ that was unprovoked. He denied hx of inactivity, long \nflights, or stasis. On ___, he presented to the ___ ED iso \nworsening RLE swelling and pain similar to the pain from his \n___ LLE DVT. A CTA chest was done that revealed pulmonary \nemboli of the lobar, segmental, and subsegmental pulmonary \narteries of the R middle and lower lobes, as well as multiple \npulmonary nodules measuring up to 6 mm in the R upper and L \nupper lobes. He was started on heparin gtt as well as his home \ncardiac medications. Heparin was discontinued and apixaban \nstarted ___ for indefinite a/c outpatient treatment. His \naspirin was continued (lower dose) after speaking with \noutpatient cardiologist. Likely related to Factor 5 Leiden \ndeficiency (worked up at ___ - records requested, had not \narrived prior to D/C). \n\n #HTN: Patient's BPs were 180s/110s when he first arrived to the \nfloor. This was likely ___ to not taking evening dose of \nmedication. SBPs outpatient have been 130s. His SBPs on the \nfloor have remained in the 150s-160s stably. He denied any HAs, \nvision changes, and was neurologically intact. He was continued \non home medications: Isosorbide Mononitrate, Lisinopril, \nMetoprolol, Carvedilol. His BP was monitored for a goal SBP of \n<150s.   \n\n #Systolic CHF (LVEF 40-45% ___  \nCHF stable at time of last echo in ___. He was not on standing \nLasix at home. He did not appear volume-up. He was continued on \nlisinopril, metoprolol, Carvedilol.   \n\n ==============  \n CHRONIC ISSUES  \n ==============  \n #Coronary Artery Disease, s/p MI w 3 stents and CABG  \n Last seen by Cardiology ___ having some anginal Sx at that \ntime and increased on Isosorbide mononitrate from 60 to 120mg. \nHe was continued on home lisinopril, isosorbide mononitrate, \nmetoprolol tartrate, carvedilol, aspirin,  \n\n #Gout  \n - His colchicine PRN  was held. \n\n #DMT2  \n Held oral medications. He was monitored using insulin sliding \nscale.  \n\nTRANSITIONAL ISSUES:\n==========================================================\n# Occult malignancy: DVT likely in setting of Factor 5 \ndeficiency. Cannot exclude malignancy. Consider repeat CT chest \n___ year (has nodules), also consider repeating other age \nappropriate cancer screening. \n\n#HTN\nSBPs during admission in the 160-180s. ___ need uptitration of \nmedications. Discharged pressure 170/84.\n\n#Anticoagulation:\nApixiban selected as anticoagulation agent for this patient \nafter discussing risks/benefits with patient and following up \nwith his outpatient cardiologist. He will be on 10 mg BID for \nthe first 7 days and then 5 mg BID thereafter. \n\nMEDICATION CHANGES\n\n* Apixaban 10 mg PO every 12 hours, end date ___ morning dose\n* Apixaban 5 mg PO every 12 hours on going until you follow up \nwith your primary care doctor\n* Aspirin 81 mg PO DAILY You were taking this medication at home \nbut there has been a change in dose (had been taking 325 mg \ndaily at home)\n\nCode status: Full presumed\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Carvedilol 12.5 mg PO BID \n2. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY \n3. Lisinopril 40 mg PO DAILY \n4. MetFORMIN (Glucophage) 1000 mg PO BID \n5. Simvastatin 80 mg PO QPM \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Aspirin 325 mg PO DAILY \n8. GlipiZIDE 10 mg PO BID \n9. Benzonatate 100 mg PO TID:PRN cough \n10. Colchicine 0.6 mg PO ONCE:PRN gout \n11. Metoprolol Tartrate 25 mg PO BID \n12. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n13. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Medications:\n1.  Apixaban 10 mg PO BID  \n2.  Apixaban 5 mg PO BID \nPlease start after the 7 days of twice daily 10 mg Apixaban \nRX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth every twelve \n(12) hours Disp #*60 Tablet Refills:*0 \n3.  Aspirin 81 mg PO DAILY  \n4.  Benzonatate 100 mg PO TID:PRN cough  \n5.  Carvedilol 12.5 mg PO BID  \n6.  Colchicine 0.6 mg PO ONCE:PRN gout  \n7.  Cyanocobalamin 1000 mcg PO DAILY  \n8.  GlipiZIDE 10 mg PO BID  \n9.  Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY  \n10.  Lisinopril 40 mg PO DAILY  \n11.  MetFORMIN (Glucophage) 1000 mg PO BID  \n12.  Metoprolol Tartrate 25 mg PO BID \nRX *metoprolol tartrate 25 mg 1 tablet(s) by mouth twice a day \nDisp #*60 Tablet Refills:*0 \n13.  Multivitamins 1 TAB PO DAILY  \n14.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain  \n15.  Simvastatin 80 mg PO QPM  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nRLE DVT\nPulmonary embolism\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n Dear Mr. ___, \n \nIt was a pleasure taking care of you at ___ \n___.  \n\n Why was I hospitalized?  \n - You had a clot in your right leg.\n  \n What happened while I was in the hospital?  \n- You had an ultrasound of your right leg that showed a clot in \nyour right lower leg. You had a CT chest that showed a clot in \nyour lungs. You were given heparin anticoagulation in order to \nthin the blood and prevent the clots from getting bigger. You \nwere continued on your other home heart medications.  \n\n What should I do when I go home?  \n- You should follow up with your PCP and cardiologist \n\nMEDICATION CHANGES\n* Apixaban 10 mg PO every 12 hours, end date ___ morning dose\n* Apixaban 5 mg PO every 12 hours on going until you follow up \nwith your primary care doctor. \n* Aspirin 81 mg PO DAILY  You were taking this medication at \nhome but there has been a change in dose \n\n We wish you all the best,  \n Your ___ Team  \n \nFollowup Instructions:\n___\n"
}